Crossmark

A safe and efficacious Pt(<scp>ii</scp>) anticancer prodrug: design, synthesis, <i>in vitro</i> efficacy, the role of carrier ligands and <i>in vivo</i> tumour growth inhibition

Crossref DOI link: https://doi.org/10.1039/C8CC06586A

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Dutta, Pradip Kumar

Sharma, Rupali

Kumari, Smita

Dubey, Ravindra Dhar

Sarkar, Sujit

Paulraj, Justin

Vijaykumar, Gonela https://orcid.org/0000-0002-1249-7347
Pandey, Manoj

Sravanti, L.

Samarla, Mallik

Das, Hari Sankar

Yashpal, Yashpal

B., Heeralal

Goyal, Ravinder

Gupta, Nimish https://orcid.org/0000-0002-9857-1025
Mandal, Swadhin K. https://orcid.org/0000-0003-3471-7053
Sengupta, Aniruddha

Sarkar, Arindam https://orcid.org/0000-0002-5946-2846
Funding

Funding for this research was provided by:

Science and Engineering Research Board (EMR/2016/000357)
License Information

Accepted Manuscript valid from 2019-12-20
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

: Crystal Structure Data

IDENTIFIERS

: Gonela Vijaykumar (ORCID)

: Gonela Vijaykumar (ResearcherID)

: Nimish Gupta (ORCID)

: Swadhin K. Mandal (ORCID)

: Arindam Sarkar (ORCID)

PEER REVIEW METHOD

: Authors can choose between single-blind and double-blind peer review

PUBLICATION HISTORY

: Received 13 August 2018; Accepted 20 December 2018; Accepted Manuscript published 20 December 2018; Advance Article published 9 January 2019; Version of Record published 5 February 2019

Document is current

Any future updates will be listed below